Becton Dickinson and Company
BDX
$188.98+0.86%
End of day · as of Oct 15, 2026, 2:00 AM ET
Mkt cap
$50.30B
EV/Sales
3.15
P/E ratio
57.1
FY2025 Revenue
$21.84B
EPS (TTM)
$3.31
Gross Margin (FY2025)
45.44%
Profit Margin (FY2025)
7.68%
Beta
0.28
Div yield
2.42%
Sector
Healthcare
No recent filings in cache.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 57.1.
Use this BDX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BDX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Becton Dickinson and Company (BDX) is a medical instruments & supplies company in the Healthcare sector.
Latest cached Becton Dickinson and Company (BDX) revenue for Sep 30, 2025 was $21.84B. Net income was $1.68B. Statements: https://lician.com/financials/bdx
Becton Dickinson and Company (BDX) trailing P/E is 57.1 on the latest cached fundamentals snapshot.
Becton Dickinson and Company (BDX) market capitalization is $50.30B on the latest cached snapshot.
Becton Dickinson and Company (BDX) cached previous close $187.37; day range $188.48 – $188.98; volume 1,630,945. Session quote: https://lician.com/quote/bdx
Becton Dickinson and Company (BDX) latest cached earnings event is "BDX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings